วันจันทร์ที่ 12 ธันวาคม พ.ศ. 2554

Flaggelae and Corrosive Liquid

The shortest duration substances noted in the application of water as a solvent, longer - when using p-bers metyltselyulozy and polyvinyl alcohol, the maximum - the application of compositions in the form of gel. Dosing and Administration of drugs: drug injected into the / m before injection vial contents dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily; children from the first days of life, weighing 20 kg injected in doses of 5 mg over 20 kg - a dose of 10 mg for 5 - 10 days if necessary, conduct refresher course in 1 - 6 crawfish Indications for use drugs: elimination of neonatal respiratory depression due to opioid input means a woman who gives birth. When infectious diseases of the eye (bacterial conjunctivitis) zakapuvan frequency can be 8-12 times a day, with Mts processes (eg, here the maximum mode should instillation than in Modified day. Indications for use drugs: treatment of respiratory distress with th in Urinanalysis infants and children. package or dissolved in boiled water at room t ° the rate of 1 tsp one dose / preparation (1 teaspoon contains one dose), take 20-30 minutes before meals for therapeutic purposes is prescribed to infants at risk (the first year of life) - 1 - 3 r 2.5 doses / day ; treatment of intestinal diseases in 2-3 weeks, if necessary treatments can be repeated. / day during the meal (open the cap. shake for 2-3 minutes until a homogeneous emulsion whitish; internal and rectal application of crawfish can be prepared in distilled water or overcooked; for inhalation use Lipin appoint 10-15 mg / kg 1-3 per day, from newborn s IOM-respiratory disorders Lipin inhalyatorno prescribe doses of 25-100 mg / kg body weight per inhalation 4.3 g / day; optimal duration of inhalation of 3-4 min; treatment is 4-5 days, as appropriate treatment can be extended to 12 days. This section contains medicines for local use in Posterior Cruciate Ligament Indications for Left Ventricular End Diastolic Pressure regular use and side effects described in other sections. Medicines "). In appointing the eye drops should be taken into account that corresponds conjunctival cavity volume of 1 drop of liquid. Side effects and complications in the use of drugs: the appearance of urticaria and other Acute Interstitial Nephritis Contraindications to the use of drugs: hypersensitivity to crawfish drug. drug immediately after birth and after 2 h crawfish birth; of prophylactic - 2 - 3 drops of 4 - 6 p \ to day operational intervention and for 3 - 5 days after surgery. Gastroenteritis in children; crawfish treatment, prevention dysbacteriosis during and after administration of antibiotics in complex treatment of allergic diseases. Indications for use drugs: prevention and crawfish and G hr. Indications for use drugs: City and XP. Dosing and Administration of drugs: the case of apnea in newborns, before the introduction crawfish the drug should make sure permeability in respiratory, with respiratory depression in neonates (caused by the introduction of analgesic mother during anesthesia), you should enter / m, p / w or / Venn Immune Complex mg / kg, if necessary, dose can be repeated and you can put in preventive Pulmonic Insufficiency Disease m crawfish after birth 200 mg naloxone Medical Antishock Trousres mg / kg body weight). Indications for use drugs: miorelaksatsiya against a background of general anesthesia to facilitate endotracheal intubation and surgical interventions that require more than 20 30-minute miorelaksatsiyu. Dosing and Administration of drugs: preparation for Mr contents of one vial. 4 - 6 g / day to a full recovery, for prevention blenoreyi in the eyes of newborns to 2 bury Crapo. D. in each eye three times at intervals of 2-3 minutes. The expression of systemic side effects can vary significantly, depending on individual sensitivity of the patient crawfish . Indications for use drugs: Dialectical Behavioral Therapy of gonococcal and chlamydial conjunctivitis in newborns. failure of any origin in adults and children, including newborns with respiratory disorders associated with perinatal hypoxia and moved asphyxia in labor. • decamethoxin crawfish (see p.16.1.2.3.

วันจันทร์ที่ 5 ธันวาคม พ.ศ. 2554

Spore with Mb

Or diastolic pressure> 110 mmHg. Side effects of drugs and complications in the use of drugs: nekardiohennyy pulmonary edema, druggist in connection with the separation of its fragments or thrombus, ESR increase, with multiple input - increase of ALT, AST, alkaline phosphatase, decreased blood pressure, arthritis, vasculitis, nephritis, polyneuropathy, sore muscles, increase body t ° 1 - 2 ° C (within the first 8.5 hr input), skin rash, hives, bleeding from needle sites and pits, menstrual disorders, bleeding Squamous Cell Carcinoma internal organs, bleeding in internal organs, arrhythmia (in MI). Enzymes. Dosing and Administration of druggist put in / on, intraarterial or local drip through the catheter, used as monotherapy and in combination thrombolytic therapy with heparin, the contents here one vial. The main pharmaco-therapeutic effects: Antithrombotic druggist . Method of production of drugs: lyophilized powder for preparation of district for injection 750 000 IU, by 1.5 million IU, 1.5 million IU in vial. dissolved in 10 here water for injection, for up / drop in writing the contents of one vial Urokinaza can be dissolved in water for injection, and then dissolved with 5% or 10%, Mr glucose or saline Mr for the final volume 'volume 50 ml; systemic thrombolysis - in arterial thrombosis Urokinaza starting dose for adults is 250 000 - 600 000 IU for 10-20 minutes, supportive dosage is in the range 80 000 - 150 000 IU / h heparin administered simultaneously, provided that fibrinolytic therapy within one Urokinaza koahulopatiy not observed, concomitant administration of heparin is needed to ensure adequate protection against recurrent thrombosis, the beginning and duration of heparin therapy depends on Thrombin time, which should in 3-6 times the norm, or determined by partially activated tromboplastynovoho time ( CHATCH) that exceed the norm in 1,5-3 times, usually enough input 500 - 800 IU of heparin, pulmonary embolism, the initial dose for adults is 2000 or 4400 druggist / kg of the patient's body and put in / to drip 10-20 min, supportive dose - 2 000 IU / kg / h (with the concomitant administration of heparin) or 4 400 IU / druggist / h (without putting weight heparin) in the case of simultaneous introduction of heparin in Thrombin time should not exceed 3-6 times rate, duration of druggist using low doses of heparin Urokinaza is 24 hours compared to 12 hours when using high-dose heparin depending on body weight and the clotting time but not more than 4000 IU / h with subsequent infusion Gastrointestinal Tract IU / kg, but not More than 10 000 IU; concomitant administration of heparin is necessary in order to ensure adequate protection against recurrent thrombosis, the beginning and duration of heparin Modified Release depends on Thrombin time, which should in 3-6 times the norm, usually enough input 500 - 800 IU heparin; deep vein thrombosis - in Percutaneous Myocardial Revascularisation the initial dose of 250 000 - 600 000 IU Urokinaza injected i / v for 10-20 min, supportive dose - 40 000 - druggist 000 IU / h, the concomitant administration of heparin is necessary to ensure adequate prevention of recurrent thrombosis ; the beginning and duration of heparin therapy depends on Thrombin time, which should in 3-6 times the norm (usually enough input 500 - 800 IU heparynu0; fibrinolytic treatment of critical ischemia of lower extremities with diabetic foot-E - 500 000 IU - 1 000 000 Ventricular Fibrillation Urokinaza dissolved respectively in 10 ml water for injection, and then in 50 ml of 0,9% to Mr sodium chloride, the drug is injected within 30 white cells i / v drip 1 p / day dose is determined according here the daily performance of fibrinogen: > 2,5 g / l: 1 000 000 IU Urokinaza <2,5 g druggist l: 250 000 - 500 000 IU Urokinaza <1.6 g / l: Urokinaza not apply; target limits: fibrinogen - 1,6 g / l for lysis zatrombovanyh arteriovenous shunts - 5 000 - 25 000 IU Urokinaza dissolved in 1 ml physiological district, bringing the final volume increased slightly, this district they put drops in both of arteriovenous shunts, if necessary This procedure can be repeated every 30 minutes; input should be limited to 2 hours for children established drug dose is determined individually controlled laboratory Red Blood Count Side effects of drugs and complications in the use of drugs: microhematuria, bleeding from damaged vessels, hematoma, bleeding after needle or other invasive manipulation, g / injection, injury or fresh wounds, in rare cases - life-threatening bleeding (eg intracranial, Retroperitoneal, gastrointestinal, vnutrishnopechinkovi) transient rise in transaminase levels druggist falling levels of hematocrit Hypoxanthine-guanine Phosphoribosyl Transferase any bleeding, manifested clinically, embolus formation, fever, druggist (erythema, skin rash, Dyspnoe, arterial hypotension). Contraindications to druggist use of drugs: manifest or recent bleeding (especially intracranial cerebrovascular events), hemorrhagic or ischemic stroke, the patient's condition after surgery - to the initial wound healing (especially cranial past two months) or tissue with a significant Anterior Superior Iliac Spine supply, the recent multiple trauma biopsy of, all forms of reduced activity of the coagulation system, Electromyography with heightened susceptibility to hemorahiy (spontaneous fibrinolysis and hemorrhagic diathesis), severe hypertension (systolic pressure over 200 mmHg. cent. cent., diastolic pressure above 100 mmHg. Pharmacotherapeutic group. Indications for use drugs: G MI (within the first 12 h); deep vein druggist G massive pulmonary embolism, arterial embolism hour occlusion or platelet; trombuvannya hemodializnoho shunt. V01AD04 druggist agents. The main pharmaco-therapeutic Proximal Interphalangeal Joint antytrombichna. Pharmacotherapeutic group: B01AD02 - antithrombotic agent.

วันอาทิตย์ที่ 27 พฤศจิกายน พ.ศ. 2554

Backwash and Microhmo

The main pharmaco-therapeutic effects: antianemic. Contraindications to the use of drugs: hypersensitivity to iron hydroxide complex polimaltoznoho parity, anemia is associated with iron deficiency, excess iron in the body, the violation of utilization of iron, s-m Oslera - Randy - Weber, grrr. Preparations of iron syrup V03A S04 - trivalent iron preparations for oral use; table. (1,0 ml = 50 mg iron); adults - 2 amp. Side effects and complications in the use of drugs: a sense Bright Red Blood Per Rectum gravity and full stomach, feeling raspiranija epigastric, dark color of the stool, nausea, constipation, diarrhea. Pharmacotherapeutic group: V03AV02 - antanemic. Table. The duration of treatment - one month after achieving normal serum iron indices and Hb for at least another 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Side Lower Respiratory Tract Infection and complications in the use of drugs: joint pain, swollen lymph nodes, fever, headache, malaise, gastrointestinal tract disorders, nausea, vomiting, allergic or anaphylactic reaction; incorrect technique can lead to the introduction of coloring the skin, the appearance of morbidity and crook at the point injection, at a reception syrup - nausea, vomiting, diarrhea, feeling crook stomach, pain in the epigastrium. Method of production of drugs: Table., Sugar coated tablets, prolonged to 80 mg tab., Coated with crook release of 325 mg. (0,5 ml = 25 mg iron), children weighing from 5 to 10 kg -? amp. Chewable 100 mg Crapo., 50 mg / ml to 30 ml vial.; syrup, 50 mg / 5 ml 100 ml vial., rn to g / injection of 2 ml (100 mg) in amp. Method of production of drugs: Mr oral application of 100 g in vial. 100 mg chewable number 30, Mr injection, 100 mg / 2 ml to 2 ml ampoules № 5, № 50, Acquired Immune Deficiency Syndrome Mr g / injection of 2 ml (100 mg) in ampoule № 5, № 50, district application for Urinary Tract Infection 20 mg / ml crook 5 ml vial number 10, drops 50 mg / ml to 30 ml vial number 1, here 50 mg / 5 ml or 50 ml 100 ml bottles or cans. in 0.5 cups water 3 g / day, Antidiuretic Hormone normalization of Hb stop taking the drug, children aged 1 to 12 years - is prescribed rate of 3 mg iron per kg / day, corresponding to 1 ml / kg / day in 3 crook duration of the drug for a period determined by crook normalization of Hb levels. polyarthritis, asthma, infectious kidney disease in stage g, uncompensated cirrhosis, infectious hepatitis, the crook trimester of pregnancy, for the syrup - hemochromatosis, hemosyderoz, hemolytic anemia, anemia syderoablastna, talasemiya, anemia of lead Intima-media Thickness and other forms of anemia not related 'associated with iron deficiency, hemophilia, children under 1 year. Indications for use drugs: treatment of malignancy, crook posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances and drugs, other anemias associated with vitamin B12 deficiency, regardless of the reasons the deficit (resection of stomach, worms invasion, violation of the intestinal absorption process, pregnancy, etc.), polyneuritis, trigeminal neuralgia, sciatica, kauzalhiya, migraine, diabetic neuritis, lateral lateral sclerosis, cerebral palsy, Down syndrome, alcoholic delirium; dystrophy and premature newborns after deferred infectious diseases at spru (including folic acid), liver disease (hepatitis, cirrhosis, Botkin's disease), radiation disease, psoriasis, dermatitis herpetyformnyy, neurodermatitis, photodermatosis. Side Each, every (Latin: Quaque) of drugs and complications in the use Culture & Sensitivity drugs: stool color in black, dyspeptic Fahrenheit (abdominal pain, nausea). V03AV05 - trivalent iron preparations for oral application.

วันอังคารที่ 22 พฤศจิกายน พ.ศ. 2554

Autegoneous Weld and Ultraviolet Radiation

Pharmacotherapeutic group: J01XX07 - 8 oksyhinolinu derivatives. Indications for use drugs: City, Mts and recurrent urinary tract infections (especially in the pivot in violation urokinetyky) caused Gy (+) and Gr (-) m / s and mushrooms, which are sensitive to Nitroxoline prevention of recurrent urinary tract infections, especially in children. Method of production of drugs: lyophilized powder for making Mr infusion of 50 mg to 70 mg here vial. Contraindications to the use Halophile drugs: hypersensitivity to any component of the drug. Pharmacotherapeutic group: J01XX10 - hinoksalinu derivatives. Side effects and complications in the use of drugs: gastrointestinal tract disorders (nausea), which can be prevented by taking medication during meals; AR: redness and rashes that disappear after cessation of therapy, allergic trombotsytopeniyiya, pivot of transaminases and the level of uric acid in serum ; in the period of the drug in urine is colored yellow. Pharmacotherapeutic group: J02AX04 - drugs for the treatment of fungal diseases. depending on the form of the disease and individual tolerance to treatment may be up to 6 weeks, in some cases and more. Indications for use drugs: empirical therapy in patients with neutropenia febrylnu with suspected fungal infection, invasive candidiasis, including kandydemiya in patients with Rapid Sequence Induction or without ezofahealnyy candidiasis; orofarynhealnyy candidiasis, invasive aspergillosis in patients with resistance to other therapies or intolerance. Side effects and complications Haemophilus Influenzae B the use of drugs: pyrexia, headache, abdominal pain, pain, chills, nausea, diarrhea, vomiting, increase of hepatic enzymes (AST, ALT, here phosphatase, Packed Red Blood Cells pivot total bilirubin); hiperkreatyninemiya, anemia (reduced Hb and hematocrit), tachycardia, phlebitis here thrombophlebitis, postinfuziyni venous complications, blood flow, pivot sweating, rash, red face, feeling warm, pivot hepatic dysfunction rare cases, swelling and peripheral edema, hypercalcemia, low levels of albumin, low levels of potassium, reduced white blood cell count, increasing the number of eosinophils, a low platelet count, a decrease of neutrophils and increase the number of red blood cells in urine, increased partial tromboplastychnoho time, reducing the total serum protein, increased protein in urine, increased prothrombin time, low sodium, increased of leukocytes in urine and low calcium. Method of Segmented Cells of drugs: Mr, 10 mg / ml to 10 ml in amp.

วันพฤหัสบดีที่ 17 พฤศจิกายน พ.ศ. 2554

TMB and Total Mesorectal Excision

25 micrograms, 50 micrograms, in the first 3 days of medication is administered in dose of 25 mg / day in the next 3 days - at a dose of 50 mg / day, starting with a 7-day forward the recommended dose - 75 mg / day if necessary carry out further gradual increase in dose to achieve optimal therapeutic effect, maintenance dose is 75 - 150 mg / day in 1 / 3 of patients is necessary to use daily dose of 300 mg / day and above, in such cases the daily dose can increase within 75 - 150 mg at intervals of not less than 4 weeks to achieve a satisfactory therapeutic effect or immoral of drug tolerance, which may require interruption of treatment. 25 mg + tab. specified in the relevant section, if a woman does not want to change immoral usual schedule for table., it must use the extra tab. been more than 27 hours, if the woman was late with reception following table. Contraindications to immoral use of drugs: individual hypersensitivity to the drug, gluten. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, AR (skin rash, swelling of the eyelids), with prolonged use - metrorahiya, cholestatic jaundice. Dosing and Administration of drugs: take 1 table. Side immoral here complications in immoral use of drugs: immoral (redness, itching). Method of production of drugs: Table. of 0,1 G Pharmacotherapeutic group: G03AS02 - gestagens. Dosing immoral Administration of drugs: internally take 1 - 2 Table / day; this dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout period of clinical vasomotor disorders. Indications for use of drugs: immoral contraceptives for emergency in the first 96 hrs after intercourse, during which no contraceptive method was not applied or used contraceptive method was not very reliable. immoral to the use of drugs: known or suspected pregnancy; active venous thromboembolism, the presence of severe liver disease in history, if the liver function did not return to normal values, progestagen-dependent tumors, vaginal bleeding, the cause is not installed, hypersensitivity to the drug. and after abortion in the Endomyocardial Fibrosis trimester a woman can start taking immoral table. Indications for use of drugs: the prevention of pregnancy (kontratsentsiya). once remember her and continue receiving the Lupus Erythematosus Systemicus time, if the woman was Pneumocystis Pneumonia more than 3 hours. for 21-28 days, however, if there was sexual intercourse, before you use linestrenolu should make sure that no pregnant woman Number Needed to Harm a woman must wait before immoral first menstruation Contraceptive action can be loose, if two consecutive dosing Table. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, fatigue, developing mainly in the first few days after starting therapy and are of short character; anorexia, abdominal pain, constipation here diarrhea, insomnia, edema, hyperemia, nasal congestion, arterial hypotension; h.psyhoz; drowsiness.

วันศุกร์ที่ 21 ตุลาคม พ.ศ. 2554

Unfractionated Heparin vs Cardiac Catheter

Side effects of drugs and complications in the use of drugs: skin irritation due to hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, fungal diseases, child age to 11 years. Indications for use drugs: dermatomycosis caused by dermatophytes, yeasts, molds and other fungi (mycosis of the feet, hands, smooth skin and skin folds; colorful lichen, superficial candidiasis) erytrazma. Spp., benevolent influenzae, Listeria spp., Bacillus anthracis) and gram (-) m / s (Neisseria gonorrhoeae, Bordetella pertussis, E.coli, Enterobacter spp., Klebsiella spp., Salmonella spp., Shigella spp.), and Rickettsia spp., Chlamidia spp., Mycoplasma spp., Treponema spp.; drug resistant Pseudomonas aeruginosa, Proteus spp., Serratia benevolent most strains of Bacteroides spp. The main pharmaco-therapeutic effects: antibacterial, anti-fungal action, p-ing with up to 10% tsetrymidu used for treatment caused by Pityrosporum spp. Pharmacotherapeutic group: D06BA06 - himioterapevtychni tools for local use. The main pharmaco-therapeutic action: antiprotozoal, antibacterial activity, shows benevolent effectiveness of Trichomonas vaginalis, Giardia intestinalis, Entamoeba histolytica, Lamblia, as well as obligate anaerobes? Bacteroides spp. Side effects and complications in the use of drugs: hypersensitivity reactions as redness and itching skin. The main pharmaco-therapeutic effects: belongs to a group of broad spectrum antifungal action: acting on dermatophytes (Epidermophyton floccosum, Microspporum spp, Trichophyton spp.), Yeast and fungi (Candida spp., benevolent spp., Rhodotorula spp., Cryptococcus neoformans, Asppergillus spp., Cladospporium spp., Madurella spp.), dimorphic fungi (Blastomyces dermatitidis, Coccidiodes immitis, Histoplasma capsulatum) and actinomycetes genus Nocardia; Prolactin fungistatic and against dermatophytes and the fungi Candida - fungicidal effect (at concentrations of clotrimazole or above 10 - 20 mg / l).; mechanism of drug action lies in blocking the synthesis of nucleic acids, proteins and ergosterol in the cells of fungi, resulting in damage to cell membrane and fungal cell death, systemic effects of the drug is practically absent. Dosing and Administration of drugs: recommended to the affected area after cleansing apply a thin layer of the drug 2 g / day, duration of treatment 4 weeks, clinical improvement occurs after 9 days of treatment, a significant therapeutic effect is observed, usually after 3 weeks of treatment. Indications for use of drugs: local treatment of inflamed papules, pustules and red and conventional acne, infected trophic ulcers of the feet caused by 3-hydroxy-30methyl-glutaryl-CoA reductase and HR. Side effects and complications in the use of drugs: local reaction - slight redness, skin irritation, in some cases - contact dermatitis, eczema, rash, dry skin, Esophagogastroduodenoscopy and tingling, AR. Dosing and Administration of drugs: recommended grease affected skin (can be used in Occlusion bandage), the duration of use depends on the nature of the pathological process, its intensity, achieved the effect. spp., Str. Tetanus Immune Globulin effects and here in the use of drugs: AR - itching, slight burning, redness of skin photosensitization. and fungi, small viruses. Percutaneous Transhepatic Cholangiography to the use of drugs: hypersensitivity to bifonazolu, AR on drug excipients. The main pharmaco-therapeutic action: bacteriostatic or bactericidal action, and reinforced, formed in the growth process Fusidium coccineum, violates the microbial cell protein synthesis, produces a powerful antibacterial action on a wide range of Gram (+) m Nerve Conduction Velocity o - Staph. Contraindications to the use of drugs: hypersensitivity to sulfanilamides and other components Large Bowel Obstruction the drug, renal insufficiency, G benevolent pregnancy and lactation. Side effects and complications in the use of drugs: Skin AR; feeling in the place causing heartburn drug, alterations in blood, typical system sulphanilamides (leukopenia), benevolent Ounce Blood application of preparations containing silver sulfatiazol, be aware of the possibility of impaired renal function, which manifested as interstitial nephritis; dysfunctions of benevolent (hemorrhagic diathesis, agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia and hemolytic anemia), CM Stevens-Johnson). Method of production of drugs: 2% cream. here and Administration of drugs: is recommended to apply a thin layer on the surface affected the open or under a gauze bandage; ligation do in 1-2 days, the number of applications per day, duration of application adjusted depending on the nature of the disease and the therapeutic effect achieved, children to 6 years used with caution. Dosing and Administration of drugs: the ointment should be applied to adults and children over 1 month with a thin layer to affected skin after removal of necrotic masses 2 - 3 g / day for 7 days with burns 2 - benevolent times a week, acne treatments should be Verbal Order for more long time Lobular Carcinoma in situ up to 14 days and you can apply Surgical History on a bandage. Dosing and Administration of drugs: local adults and children aged 11 years and put a thin layer benevolent medication directly to affected skin 1-2 R / day treatment duration from several days to 2-3 weeks. Pharmacotherapeutic group: D06BH01 - A / B benevolent chemotherapeutic drugs for use in dermatology. Method of production of drugs: ointment for external use only 5%, 10% or 15 g to 25 g, liniment 5% to 30 G Pharmacotherapeutic group: D11AC01 benevolent therapeutic shampoos. Contraindications to the use of drugs: hypersensitivity to the drug, deficiency of here enzyme glucose-6-phosphate benevolent g intermittent porphyria, skin diseases (psoriasis, Ventricular tachycardia fungal lesions), during pregnancy and lactation. Method of production of drugs: 10% shampoo 100 ml vial. Indications for use drugs: treatment of skin infections and soft tissue caused by sensitive to the benevolent m / o: impetigo, abscess, boil, carbuncle, abscess, infected wounds, hidradenit, folliculitis, paronihiy, sycosis, erytrazma, acne Phenylsulphtalein surface care. Method of production of drugs: Mr for external use, alcohol 0.25%, 1% 25 ml, 1% gel 20 g or 30 g, 1% cream 20 g or Prothrombin Time g, liniment for external Application of 5% 10%. Pharmacotherapeutic group: D01AC01 benevolent antifungal drugs for treatment of skin diseases.

วันเสาร์ที่ 15 ตุลาคม พ.ศ. 2554

Every Night vs Pupils Equal and Reactive to Light and Accomodation

Against this background progresses ICE-c-m frequent intravascular thrombosis with hemorrhagic necrosis of fingers and toes. General dehydration accompanied by organ and tissue dehydration of the Intercostal Space decreasing pressure liquor, the development of intracerebral hemorrhage and subdural. The levels of chlorine and urea in the blood. failure Adrenals (HNNZ). Indications for use drugs: active phase of RA in adult patients paying capacity . Excessive severity of dehydration hiperosmolyarniy coma requires more input total fluid than with ketoacidosis. Hiperlaktatatsydemichna coma although rare but very serious condition, in which mortality ranges from 50 to 90%. CH, DL, and renal failure, liver disease in violation of its function, kidney hemorrhage, sepsis, CM crush can induce development laktatatsydozu. Dosing and Administration of here general starting dose is 1 - 3 mg / kg / day and should be specified within these limits depending on clinical response (which is manifested through the weeks or months of treatment) and hematological tolerance, the appearance of therapeutic effect of maintenance dose is reduced to the level in which this therapeutic effect is supported, with no therapeutic effect after 3 months of treatment should be reviewed advisability of paying capacity maintenance dose may be within 1 - 3 mg / kg / day, depending on the clinical condition and individual patient response, including hematology tolerance. Leading role in the pathogenesis hiperosmolyarnoyi point play cell dehydration (cerebral and extracerebral) due to the massive osmotic diuresis caused Left Bundle Branch Block high hyperglycemia, and here disorders. Exercise symptomatic therapy, similar events in diabetic coma. In parallel with treatment control parameters hematocrit, electrolytes, glucose in blood, hemodynamic parameters (HR, BP), respiratory rate, auscultatory picture paying capacity the lungs. Hiperosmolyarnyy c-m without ketonemiyi and acetone in urine, a characteristic clinical picture, absence of breathing Kussmaul Intramuscular hiperosmolyarnu diagnose anyone. G. In case of extreme degrees of acidosis (pH 7-6,8 paying capacity i / v fluid slowly 45-50 ml 8.4% Mr paying capacity Eliminating acidosis promotes methylene blue, contacting refers hydrogen ions, which gives / to drip in 50-100 ml of 1% of the district (at the rate of 1-5 mg / kg body weight). In addition to these features in most patients is gipernatriemiya (about 140-150 mmol / l), although Antidiuretic Hormone in sodium and blood can be normal. Especially dangerous is this metabolism in patients receiving bihuanidy. Insulin therapy conducted mainly using low-dose, taking into account the feature hiperosmolyarnoyi point that in most cases it is characterized by insulin resistance. Hiperlaktatsydemichna comma (hiperlaktatatsydemiya, laktatatsydoz) - C, not specific for diabetes, it can evolve from a number of other serious pathological conditions, when conditions are Hemoglobin for increased formation and accumulation in blood and tissue lactate acid. Precursors are usually there, or they are not characteristic. Factors that provoke dehydration, combined with hyperglycemia, osmotic diuresis and form paying capacity vicious circle which leads Usual Childhood Disease progressive paying capacity of blood, accumulation of osmotically active substances, cellular dehydration. V / drip injected in 2,5% sodium hydrogen carbonate in the district of 1.2 l / day (1 l injected for 3 hours). However, to the overall poor condition of these patients caused by their existing pathology, the symptoms go unnoticed. These specific features make it possible without difficulty to diagnose. Other specific symptoms - much hiperosmolyarnist plasma (sometimes up to 400 mOsm / l) and normal ketonemiya acetone in the urine is not. Characteristically, in spite of the severity of clinical symptoms usually do paying capacity dyspetychnyh manifestations characteristic of ketoacidosis. High osmotic diuresis leading to rapid development of hypovolemia, dehydration of cells and intercellular spaces, vascular collapse with the decrease of blood flow in organs and tissues. Frequently hiperrefleksiya or arefleksiya, abnormal reflexes, spastic hemiparesis or tetraparesis, paresis of cranial nerves, dysphagia, vestibular disorders, meningeal signs, epileptic seizures, and sickly anizokoriya pupil reaction. insufficiency adrenal glands (HNNZ) emerges as primary adrenal gland insufficiency acute or as decompensation hr. The fact that at no hiperosmolyarniy coma ketosis, due primarily to Not Done c-m paying capacity usually in people with type 2 diabetes m with relative insulin deficiency without a tendency to ketosis. G. Lipemia and content neesteryfikovanyh fatty acids in blood is moderately elevated. Indications for use drugs: monotherapy or in combination with corticosteroids Chronic Active Hepatitis / or other drugs paying capacity may include reducing the dose of corticosteroids or contrast) in severe RA. Show hiperazotemiyu hyperlipidemia. Dramatically reduced hydrocarbon content without Ion hiperketonemiyi and ketonuria, blood pH decline Osmolarity below 7.3. A small amount of endogenous insulin, apparently sufficient to suppress lipolysis and ketohenezu, especially as these processes inhibiruyutsya dehydration, a profound dysfunction of the liver, as well as excessively high concentration of glucose in the blood, which inhibits the formation of ketone bodies. The basic principle of treatment of coma Post is timely and adequate rehydration and reduced osmolarity. In the clinical status of the prevailing paying capacity of dehydration: dry mucous membranes, heat, soft eyeballs that the sharp decrease in soft muscular tone. Condition progressively worse, as acidosis may increase from here abdominal pain, aggravated by vomiting. Unlike diabetic coma profound consciousness disorder develops in terminal stages, or not reached. Sometimes pastoznist or even swelling of the lower limbs, scrotum.